Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Site Tools

  • AAAS
  • Subscribe
  • Feedback

Site Search

Search Advanced

Originally published in Science Express on 16 March 2006
Science 28 April 2006:
Vol. 312. no. 5773, pp. 592 - 596
DOI: 10.1126/science.1123654
Prev | Table of Contents | Next

Reports

SV2 Is the Protein Receptor for Botulinum Neurotoxin A

Min Dong,1 Felix Yeh,1,2 William H. Tepp,3 Camin Dean,1 Eric A. Johnson,3 Roger Janz,4 Edwin R. Chapman1,2*

How the widely used botulinum neurotoxin A (BoNT/A) recognizes and enters neurons is poorly understood. We found that BoNT/A enters neurons by binding to the synaptic vesicle protein SV2 (isoforms A, B, and C). Fragments of SV2 that harbor the toxin interaction domain inhibited BoNT/A from binding to neurons. BoNT/A binding to SV2A and SV2B knockout hippocampal neurons was abolished and was restored by expressing SV2A, SV2B, or SV2C. Reduction of SV2 expression in PC12 and Neuro-2a cells also inhibited entry of BoNT/A, which could be restored by expressing SV2 isoforms. Finally, mice that lacked an SV2 isoform (SV2B) displayed reduced sensitivity to BoNT/A. Thus, SV2 acts as the protein receptor for BoNT/A.

1 Howard Hughes Medical Institute and Department of Physiology, University of Wisconsin, Madison, WI 53706, USA.
2 Molecular and Cellular Pharmacology Program, University of Wisconsin, Madison, WI 53706, USA.
3 Department of Food Microbiology and Toxicology, University of Wisconsin, Madison, WI 53706, USA.
4 W. M. Keck Center for Learning and Memory and Department of Neurobiology and Anatomy, University of Texas–Houston Medical School, Houston, TX 77030, USA.

* To whom correspondence should be addressed: E-mail: chapman{at}physiology.wisc.edu

Read the Full Text


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES:
Bivalent Recombinant Vaccine for Botulinum Neurotoxin Types A and B Based on a Polypeptide Comprising Their Effector and Translocation Domains That Is Protective against the Predominant A and B Subtypes.
C. Shone, H. Agostini, J. Clancy, M. Gu, H.-H. Yang, Y. Chu, V. Johnson, M. Taal, J. McGlashan, J. Brehm, et al. (2009)
Infect. Immun. 77, 2795-2801
   Abstract »    Full Text »    PDF »
Detection and Quantification of Botulinum Neurotoxin Type A by a Novel Rapid In Vitro Fluorimetric Assay.
H. Poras, T. Ouimet, S.-V. Orng, M.-C. Fournie-Zaluski, M. R. Popoff, and B. P. Roques (2009)
Appl. Envir. Microbiol. 75, 4382-4390
   Abstract »    Full Text »    PDF »
From the Cover: Engineering botulinum neurotoxin to extend therapeutic intervention.
S. Chen and J. T. Barbieri (2009)
PNAS 106, 9180-9184
   Abstract »    Full Text »    PDF »
Activation of TRPV1 Mediates Calcitonin Gene-Related Peptide Release, Which Excites Trigeminal Sensory Neurons and Is Attenuated by a Retargeted Botulinum Toxin with Anti-Nociceptive Potential.
J. Meng, S. V. Ovsepian, J. Wang, M. Pickering, A. Sasse, K. R. Aoki, G. W. Lawrence, and J. O. Dolly (2009)
J. Neurosci. 29, 4981-4992
   Abstract »    Full Text »    PDF »
A 29-amino acid fragment of Clostridium botulinum C3 protein enhances neuronal outgrowth, connectivity, and reinnervation.
M. Holtje, S. Djalali, F. Hofmann, A. Munster-Wandowski, S. Hendrix, F. Boato, S. C. Dreger, G. Grosse, C. Henneberger, R. Grantyn, et al. (2009)
FASEB J 23, 1115-1126
   Abstract »    Full Text »    PDF »
Bimodal modulation of the botulinum neurotoxin protein-conducting channel.
A. Fischer, Y. Nakai, L. M. Eubanks, C. M. Clancy, W. H. Tepp, S. Pellett, T. J. Dickerson, E. A. Johnson, K. D. Janda, and M. Montal (2009)
PNAS 106, 1330-1335
   Abstract »    Full Text »    PDF »
SV2 Renders Primed Synaptic Vesicles Competent for Ca2+-Induced Exocytosis.
W.-P. Chang and T. C. Sudhof (2009)
J. Neurosci. 29, 883-897
   Abstract »    Full Text »    PDF »
Glycosylated SV2A and SV2B Mediate the Entry of Botulinum Neurotoxin E into Neurons.
M. Dong, H. Liu, W. H. Tepp, E. A. Johnson, R. Janz, and E. R. Chapman (2008)
Mol. Biol. Cell 19, 5226-5237
   Abstract »    Full Text »    PDF »
Recovery of mouse neuromuscular junctions from single and repeated injections of botulinum neurotoxin A.
A. A. Rogozhin, K. K. Pang, E. Bukharaeva, C. Young, and C. R. Slater (2008)
J. Physiol. 586, 3163-3182
   Abstract »    Full Text »    PDF »
Novel Chimeras of Botulinum Neurotoxins A and E Unveil Contributions from the Binding, Translocation, and Protease Domains to Their Functional Characteristics.
J. Wang, J. Meng, G. W. Lawrence, T. H. Zurawski, A. Sasse, M. O. Bodeker, M. A. Gilmore, E. Fernandez-Salas, J. Francis, L. E. Steward, et al. (2008)
J. Biol. Chem. 283, 16993-17002
   Abstract »    Full Text »    PDF »
Long-Distance Retrograde Effects of Botulinum Neurotoxin A.
F. Antonucci, C. Rossi, L. Gianfranceschi, O. Rossetto, and M. Caleo (2008)
J. Neurosci. 28, 3689-3696
   Abstract »    Full Text »    PDF »
Subunit Vaccine against the Seven Serotypes of Botulism.
M. R. Baldwin, W. H. Tepp, A. Przedpelski, C. L. Pier, M. Bradshaw, E. A. Johnson, and J. T. Barbieri (2008)
Infect. Immun. 76, 1314-1318
   Abstract »    Full Text »    PDF »
Molecular Architecture of Botulinum Neurotoxin E Revealed by Single Particle Electron Microscopy.
A. Fischer, C. Garcia-Rodriguez, I. Geren, J. Lou, J. D. Marks, T. Nakagawa, and M. Montal (2008)
J. Biol. Chem. 283, 3997-4003
   Abstract »    Full Text »    PDF »
Recombinant Holotoxoid Vaccine against Botulism.
C. L. Pier, W. H. Tepp, M. Bradshaw, E. A. Johnson, J. T. Barbieri, and M. R. Baldwin (2008)
Infect. Immun. 76, 437-442
   Abstract »    Full Text »    PDF »
Mechanism of botulinum neurotoxin B and G entry into hippocampal neurons.
M. Dong, W. H. Tepp, H. Liu, E. A. Johnson, and E. R. Chapman (2007)
J. Cell Biol. 179, 1511-1522
   Abstract »    Full Text »    PDF »
Crucial Role of the Disulfide Bridge between Botulinum Neurotoxin Light and Heavy Chains in Protease Translocation across Membranes.
A. Fischer and M. Montal (2007)
J. Biol. Chem. 282, 29604-29611
   Abstract »    Full Text »    PDF »
Synaptobrevin I mediates exocytosis of CGRP from sensory neurons and inhibition by botulinum toxins reflects their anti-nociceptive potential.
J. Meng, J. Wang, G. Lawrence, and J. O. Dolly (2007)
J. Cell Sci. 120, 2864-2874
   Abstract »    Full Text »    PDF »
Single molecule detection of intermediates during botulinum neurotoxin translocation across membranes.
A. Fischer and M. Montal (2007)
PNAS 104, 10447-10452
   Abstract »    Full Text »    PDF »
Primary Cultures of Embryonic Chicken Neurons for Sensitive Cell-Based Assay of Botulinum Neurotoxin: Implications for Therapeutic Discovery.
A. M. Stahl, G. Ruthel, E. Torres-Melendez, T. A. Kenny, R. G. Panchal, and S. Bavari (2007)
J Biomol Screen 12, 370-377
   Abstract »    PDF »
Inhibition of Metalloprotease Botulinum Serotype A from a Pseudo-peptide Binding Mode to a Small Molecule That Is Active in Primary Neurons.
J. C. Burnett, G. Ruthel, C. M. Stegmann, R. G. Panchal, T. L. Nguyen, A. R. Hermone, R. G. Stafford, D. J. Lane, T. A. Kenny, C. F. McGrath, et al. (2007)
J. Biol. Chem. 282, 5004-5014
   Abstract »    Full Text »    PDF »
Identification of the protein receptor binding site of botulinum neurotoxins B and G proves the double-receptor concept.
A. Rummel, T. Eichner, T. Weil, T. Karnath, A. Gutcaits, S. Mahrhold, K. Sandhoff, R. L. Proia, K. R. Acharya, H. Bigalke, et al. (2007)
PNAS 104, 359-364
   Abstract »    Full Text »    PDF »
Two Protein Trafficking Processes at Motor Nerve Endings Unveiled by Botulinum Neurotoxin E.
G. Lawrence, J. Wang, C. K. N. K. Chion, K. R. Aoki, and J. O. Dolly (2007)
J. Pharmacol. Exp. Ther. 320, 410-418
   Abstract »    Full Text »    PDF »
Highlights From The Literature.
(2006)
Physiology 21, 229-232
   Full Text »    PDF »


To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)